Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Composition of early life leukocyte populations in preterm infants with and without late-onset sepsis

  • Julie Hibbert,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing

    Affiliations Neonatal Directorate, Child and Adolescent Health Service, Perth, Western Australia, Australia, Medical School, University of Western Australia, Perth, Western Australia, Australia, Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia

  • Tobias Strunk,

    Roles Conceptualization, Funding acquisition, Investigation, Methodology, Supervision, Writing – review & editing

    Affiliations Neonatal Directorate, Child and Adolescent Health Service, Perth, Western Australia, Australia, Medical School, University of Western Australia, Perth, Western Australia, Australia, Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia

  • Elizabeth Nathan,

    Roles Formal analysis, Writing – review & editing

    Affiliation Medical School, University of Western Australia, Perth, Western Australia, Australia

  • Amy Prosser,

    Roles Investigation, Methodology, Project administration, Writing – review & editing

    Affiliation Medical School, University of Western Australia, Perth, Western Australia, Australia

  • Dorota Doherty,

    Roles Formal analysis, Funding acquisition, Writing – review & editing

    Affiliation Medical School, University of Western Australia, Perth, Western Australia, Australia

  • Karen Simmer,

    Roles Conceptualization, Funding acquisition, Resources, Writing – review & editing

    Affiliation Medical School, University of Western Australia, Perth, Western Australia, Australia

  • Peter Richmond,

    Roles Conceptualization, Funding acquisition, Resources, Writing – review & editing

    Affiliations Medical School, University of Western Australia, Perth, Western Australia, Australia, Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia

  • David Burgner,

    Roles Conceptualization, Funding acquisition, Investigation, Methodology, Resources, Writing – review & editing

    Affiliations Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Victoria, Australia, Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia

  • Andrew Currie

    Roles Conceptualization, Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – review & editing

    A.Currie@murdoch.edu.au

    Affiliations Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia, Centre for Molecular Medicine and Innovation Therapeutics, Murdoch University, Perth, Western Australia, Australia

Abstract

Background

Composition of leukocyte populations in the first month of life remains incompletely characterised, particularly in preterm infants who go on to develop late-onset sepsis (LOS).

Aim

To characterise and compare leukocyte populations in preterm infants with and without LOS during the first month of life.

Study design

Single-centre prospective observational cohort study.

Participants

Infants born <30 weeks gestational age (GA).

Outcome measures

Peripheral blood samples were collected at 1, 7, 14, 21 and 28 days of life. Leukocyte populations were characterised using 5-fluorophore-6-marker flow cytometry. Absolute leukocyte counts and frequency of total CD45+ leukocytes of each population were adjusted for GA, birth weight z-scores, sex and total leukocyte count.

Results

Of 119 preterm infants enrolled, 43 (36%) had confirmed or clinical LOS, with a median onset at 13 days (range 6–26). Compared to infants without LOS, the adjusted counts and frequency of neutrophils, basophils and non-cytotoxic T lymphocytes were generally lower and immature granulocytes were higher over the first month of life in infants who developed LOS. Specific time point comparisons identified lower adjusted neutrophil counts on the first day of life in those infants who developed LOS more than a week later, compared to those without LOS, albeit levels were within the normal age-adjusted range. Non-cytotoxic T lymphocyte counts and/or frequencies were lower in infants following LOS on days 21 and 28 when compared to those who did not develop LOS.

Conclusion

Changes in non-cytotoxic T lymphocytes occurred following LOS suggesting sepsis-induced immune suppression.

Introduction

Late-onset sepsis (LOS; onset >72 hours of age) remains a frequent cause of morbidity and mortality in preterm infants (born <37 weeks gestation age (GA)) [1]. Risk is inversely related to GA and birth weight and LOS occurs in over 20% infants born ≤32 weeks GA [2]. Late-onset sepsis and the associated inflammation contribute to increased mortality and adverse outcomes, particularly impaired neurodevelopment [3].

Leukocytes play important roles in initiating inflammatory responses, stimulating complement pathways and activating adaptive immune responses. However, composition of early life leukocyte populations remain incompletely characterised, particularly in preterm infants who go on to develop LOS [4, 5]. Most data on neonatal leukocyte numbers and/or frequencies are derived from cord blood studies, from which immune parameters may be poorly reflective of postnatal immunity [6]. Moreover, leukocyte data are routinely obtained from manual blood films and automated blood count analysers and lack information on relative leukocyte frequencies [7, 8]. Consequently, there are few reports on leukocyte numbers and proportions preceding and following neonatal sepsis [4]. In this prospective observational study, we characterised the principal leukocyte populations during the first month of life in very preterm infants (born <30 weeks GA) with and without LOS. We hypothesised that infants who subsequently developed LOS would have differential leukocyte counts and proportions compared to uninfected infants, both preceding and following sepsis.

Methods

Study population

This prospective, longitudinal observational study of innate immune system development during the first month of life in very preterm infants born <30 weeks GA was approved by the Women and Newborn Health Services Human Research Ethics Committee at King Edward Memorial Hospital, Perth, Australia (1627/EW) [911]. Written, informed consent was obtained from parents prior to their child’s participation. Infants born at <30 weeks GA without major congenital anomalies were eligible for recruitment to this study between July 2009 and October 2011.

In accordance with local clinical guidelines, blood culture was performed if infants had clinical signs suggestive of LOS, including increased ventilation or oxygen requirements, lethargy, decreased perfusion, temperature instability, vomiting, feed intolerance, increased apnoea and/or bradycardia. LOS was defined as follows: ‘Confirmed LOS’—positive blood culture and a C-reactive protein (CRP) of >15 mg/L within 72 h of blood culture. ‘Clinical LOS’—negative blood culture and a CRP of >15 mg/L within 72 h of blood culture [9, 12]. ‘Any LOS’—infants with confirmed and clinical LOS. Infants with a Gram-positive blood culture (coagulase-negative staphylococci n = 2 and Enterococcus faecalis n = 1), 2–4 serial CRPs of <15 mg/L within 72 h of blood culture sampling and the absence of sustained clinical features of LOS were considered contaminants and analysed with infants that did not develop confirmed or clinical LOS (‘no LOS’).

Relevant demographic and clinical data until discharge from the neonatal intensive care unit were extracted from electronic patient databases. Placental histology was examined as part of routine care for infants born <30 weeks GA, using an adaption of a widely accepted semi-quantitative scoring system, as previously described [13].

Whole blood sampling

Peripheral venous blood samples (0.8 mL) were collected into Lithium-heparin tubes (BD Biosciences, North Ryde, NSW, Australia) on days 1 (n = 119), 7 (n = 111), 14 (n = 109), 21 (n = 111) and 28 (n = 111) of life and processed within 4 h of collection to characterise immune development using a number of assays [911].

Leukocyte immunostaining for flow cytometry

For this study, 50 μL whole blood samples were stained with leukocyte marker antibodies using an established 5-fluorophore-6-marker surface staining method, as previously described [14]. In brief, whole blood was incubated with a cocktail of monoclonal mouse anti-human antibodies: CD2-APC, CD36-PE, CD16-APC-H7, CD45-AmCyan, CD19-V450 and rat anti-human chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTh2)-AF647 (all BD Biosciences). Red blood cells were lysed with BD FACS Lysing Solution before fixation in Stabilizing Fixative and transfer to TruCOUNT Tubes (all BD Biosciences).

Flow cytometry analysis

Flow cytometry analysis was performed as previously described [9]. Briefly, data was acquired in real-time on a triple-laser eight-colour FACSCanto II flow cytometer with FACSDiva software (BD Biosciences). Flow cytometer fluorescence intensities were monitored weekly with SPHERO Rainbow Calibration Beads (SheroTech Inc, Lake Forest, IL, USA). An established gating strategy, validated in neonatal cord blood and critically ill newborns, was used to identify principal leukocyte populations using FlowJo version 8 software (Tree Star Inc., Ashland, OR, USA) [1416]. Leukocytes were separated from debris using positivity for the common leukocyte antigen CD45. Through successive gating, the following populations were identified: neutrophils (SSChigh/CD16+), immature granulocytes (SSChigh/CD16-/CD2-/CRTh2-), eosinophils (SSChigh/CD16-/CRTh2+), basophils (SSCint/CD16-/CRTh2+), CD16- classical monocytes (SSCint/CD16-/CD2-/CRTH2-/CD19-/CD36+), CD16+ non-classical monocytes (SSCint/CD16+/CD2-/CRTH2-/CD19-/CD36+), B lymphocytes (SSClow/CD16-/CD2-/CRTH2-/CD36-/CD19+), non-cytotoxic (CD16-) T lymphocytes (SSClow/CD16-/CD2+/CRTH2+) and cytotoxic (CD16+) T lymphocytes and natural killer (NK) cells (SSClow/CD16+/CD2+/CRTH2+), as shown in S1 Fig in S1 File. Based on the surface markers used, we speculate that the neutrophil population consists mainly of mature neutrophils and less-mature banded cells (CD16dim), the immature granulocytes includes promyelocytes, myelocytes and metamyelocytes, the CD16+ cytotoxic T/NK lymphocytes contains mostly effector CD8+ T cells, and the CD16- non-cytotoxic T lymphocytes are mainly CD4+ T cells [1723]. Other cells in the T cell compartment, such as γδ T and NKT cells are likely to be included in the non-cytotoxic and cytotoxic T/NK lymphocyte populations [24].

Statistical analysis

Continuous data were summarised as median and interquartile ranges (IQR, 25th-75th) and categorical data with frequency distributions. Group (any LOS or no LOS) allocation was made based on the whole study period (i.e. infants who developed LOS during the study period were assigned to the LOS group from Day 1). Univariate comparisons of demographic and clinical data between the any LOS and no LOS groups, and confirmed LOS and clinical LOS groups, were performed using the Mann-Whitney test for continuous outcomes and Fisher’s exact test for categorical outcomes. Absolute leukocyte counts were calculated according to BD TruCOUNT instructions by dividing the number of events in the population of interest by the total bead count and multiplying the number of beads per test, divided by the sample volume with dilutions accounted for [9]. Descriptive summaries, prior to analysis, of absolute leukocyte populations counts and frequency of total CD45+ leukocytes data are presented in S1 Table in S1 File. Leukocyte count and frequency data were transformed to the natural logarithm for analysis to fulfil the assumption of normality of the residuals. Mixed linear regression analysis using a random effects model and a group by time interaction was performed to assess the effect of LOS on leukocyte population levels, while accounting for the repeated measures at time points. All models were adjusted for known confounders, GA, birth weight z-score, sex and total leukocyte count [2]. For weekly analysis, post-hoc pairwise differences in adjusted counts between each time point were calculated within LOS and no LOS groups. Analogous analyses assessed temporal changes in leukocyte counts and frequencies, and the ratio of neutrophil counts to lymphocyte counts between groups. All post-hoc pairwise comparisons were Bonferroni-corrected to maintain an overall alpha error rate of 0.05. Model parameters were back transformed and presented graphically as geometric means and their 95% confidence intervals (CI). Stata (version 16, StataCorp, College Station, TX, USA) statistical software was used for data analysis. Prism 8 for macOS (GraphPad, La Jolla, CA, USA) was used to generate figures. P values <0.05 were considered statistically significant.

Results

Clinical characteristics of study cohort

Of the 129 very preterm infants recruited to this study, infants who suffered from early-onset sepsis (n = 4) or necrotising enterocolitis (n = 5) during the study period or had insufficient samples (n = 1) were excluded from analysis. Clinical characteristics of the analysed cohort (n = 119) are shown in Table 1. Consistent with known risk factors for LOS, preterm infants with any LOS (confirmed (n = 28) and clinical (n = 15)) were younger and smaller at birth and required more respiratory support compared to infants without LOS (n = 76; Table 1) [2]. The median age at the onset of LOS was postnatal day 13 (IQR 25th-75th 10–18 days; range 6–26 days). Three infants, all without LOS, died on days 2 and 3 due to pulmonary haemorrhage (n = 2) and extreme prematurity (n = 1). Data collected prior to death were included in the analysis and leukocyte populations were within the range of uninfected infants. Most of the confirmed LOS episodes (n = 23, 82.1%) were caused by Gram-positive bacteria, predominantly Coagulase-negative staphylococci (n = 19, 82.6%), followed by Enterococcus faecalis (n = 2), Staphylococcus aureus (n = 1) and Bacillus sphaericus (n = 1). Gram-negative infections (n = 5, 17.9%) were caused by Escherichia coli (n = 3), Enterobacter cloacae (n = 1) and Klebsiella pneumoniae (n = 1). The clinical characteristics of infants with confirmed and clinical LOS were similar except for a higher maximum CRP in the confirmed LOS group (S2 Table in S1 File).

thumbnail
Table 1. Basic clinical characteristics of the study cohort.

https://doi.org/10.1371/journal.pone.0264768.t001

Leukocyte populations during the first month of life

The adjusted counts and frequencies of neutrophil, basophil, immature granulocytes and non-cytotoxic T cells were generally different between infants with and without LOS during the first month of life (Figs 1 and 2; S3 and S4 Tables in S1 File). Neutrophil counts and frequencies were unchanged between days 1–14 and then decreased thereafter in the no LOS group, but remained lower and unchanged over time in the any LOS group. Basophil counts and frequencies peaked by day 7 and decreased thereafter in the no LOS group, yet levels remained the same after increasing from days 1 to 7 in the any LOS group. Non-cytotoxic T lymphocyte counts and frequencies increased with age during the first month of life, but were lower in the any LOS group compared to the no LOS group. Immature granulocyte counts and frequencies were unchanged on days 1–7 in both the any and no LOS groups, but decreased thereafter in the no LOS group and remained higher in any LOS until day 28. The temporal trends in counts and frequencies of classical monocytes remained unchanged during the first month of life for both the any and no LOS groups (Figs 1 and 2; S3 and S4 Tables in S1 File). Non-classical monocytes, eosinophils and cytotoxic T/NK and B lymphocytes increased with age and were generally similar between the any and no LOS groups (Figs 1 and 2; S3 and S4 Tables in S1 File).

thumbnail
Fig 1. Absolute leukocyte counts.

The absolute counts of total leukocyte, granulocyte, monocyte and lymphocyte populations from peripheral blood of preterm infants with any LOS (confirmed and clinical; closed circle) and no LOS (open circle). Analysis was performed by mixed linear regression analysis using a random effects model that was adjusted for known confounders, GA, birth weight z-score, sex and total leukocyte count. Data shown as geometric mean with 95% confidence intervals. Arrows indicate the median age of LOS onset of 13 days in infants in the any LOS group. *Comparison between preterm infants with any LOS and no LOS at the specified time point; level of significance indicated by symbols, e.g. *P < 0.05.

https://doi.org/10.1371/journal.pone.0264768.g001

thumbnail
Fig 2. Leukocyte frequency.

The percentage of total CD45+ granulocyte, monocyte and lymphocyte populations from preterm infants with any LOS (confirmed and clinical; closed circle) and no LOS (open circle). Analysis was performed by mixed linear regression analysis using a random effects model that was adjusted for known confounders, GA, birth weight z-score, sex and total leukocyte count. Data shown as geometric mean with 95% confidence intervals. Arrows indicated the median age of LOS onset of 13 days in infants in the any LOS group. *Comparison between preterm infants with any LOS and no LOS at the specified time point; level of significance indicated by symbols, e.g. *P < 0.05.

https://doi.org/10.1371/journal.pone.0264768.g002

Leukocyte populations at each time point

Neutrophil and non-cytotoxic T lymphocyte counts and/or frequencies were associated with LOS. Adjusted neutrophil counts were lower in infants with any LOS than those with no LOS on day 1 (mean 1.57x109/L vs 2.26x109/L, p = 0.011), but were similar at all other time points (Figs 1 and 2). Non-cytotoxic T lymphocyte counts and/or frequencies were lower in the any LOS group compared to the no LOS group on days 21 (mean 1.17x109/L vs 1.47x109/L, p = 0.048; 22.3% vs 27.7%, p = 0.021) and 28 (mean 23.9% vs 30.3%, p = 0.010; Figs 1 and 2). In contrast, counts and frequencies of immature granulocytes, basophils, eosinophils, classical and non-classical monocytes and cytotoxic T/NK and B lymphocytes were similar between the no LOS and any LOS groups at all time points (Figs 1 and 2).

Neutrophil-to-lymphocyte count ratio

There were no differences in the ratios of neutrophils-to-all-lymphocytes and to lymphocyte sub-populations between the any LOS and no LOS groups (Fig 3).

thumbnail
Fig 3. Neutrophil-to-lymphocyte ratios.

The ratio of neutrophils to a) all lymphocytes, b) non-cytotoxic T lymphocytes, c) B lymphocytes, and d) cytotoxic T/NK lymphocytes, from preterm infants with any LOS (confirmed and clinical; closed circle) and no LOS (open circle). Analysis was performed by mixed linear regression analysis using a random effects model that was adjusted for known confounders, GA, birth weight z-score, sex and total leukocyte count. Data shown as geometric mean with 95% confidence intervals. Arrows indicate the median age of LOS onset of 13 days for infants in the any LOS group.

https://doi.org/10.1371/journal.pone.0264768.g003

Confirmed and clinical LOS

Leukocyte populations and neutrophil-to-lymphocyte ratios were similar between infants with confirmed and clinical LOS except for an elevated frequency in non-cytotoxic T lymphocytes on day 7 in the confirmed LOS group (mean 24.6% vs 17.8%, p = 0.031).

Discussion

To our knowledge, this is the first study to characterise preterm infant peripheral blood principal leukocyte populations from a single sample taken weekly during the first month of life. We show that neutrophils, basophils and non-cytotoxic T lymphocytes were generally lower and immature granulocytes were higher over the first month of life in infants who developed LOS, compared to infants without LOS. Specific time point comparisons revealed that infants with LOS had significantly lower neutrophils on the first day of life preceding LOS and non-cytotoxic T lymphocytes were decreased following LOS.

Leukocyte populations during the first month of life

We extend the findings of previous studies that examined the development of monocyte and basophil populations to one week of age by characterising these populations through the first month of life, a time when the risk of sepsis is the highest [2528]. The counts/frequencies of the granulocyte and monocyte populations observed in our study are consistent with available previous data, obtained mainly from manual blood films and automated analyses, and some flow cytometry-based methods [8, 25, 2832]. We found counts/frequencies of non-cytotoxic T lymphocytes remained relatively stable during the first month of life, whereas cytotoxic T/NK cells and B lymphocytes increased with age, similar findings to previous longitudinal studies that have characterised the T cell compartment in preterm infants [28, 3234].

Leukocyte populations in infants with and without LOS

We report that infants who later developed LOS had lower neutrophil counts on day 1 of age, albeit within the normal age-adjusted range [29]. Neutropenia, compounded by functional impairments, has been linked to sub-optimal microbial colonisation and LOS susceptibility in murine models of sepsis [3538]. However, in human infant studies a link between early-onset neutropenia and LOS has not been confirmed [3941]. Our observation of lower neutrophil counts in infants who subsequently develop LOS is transient and potentially affected by maternal factors (e.g. pre-eclampsia, placental insufficiency) that are associated with early-onset neutropenia in newborns [41].

Basophil counts and frequencies were elevated until day 14 and declined thereafter in infants without LOS, whereas they remained consistently lower in those who developed LOS. The role of basophils in human LOS remains unclear, with most data collected from animal models. Basophil-deficient mice exhibit reduced bacterial clearance and increased mortality in sepsis models, indicating an important role for basophils in initiating an immune response to bacterial infection [42]. Our data of lower basophil counts in infants who developed LOS support a contribution of these cells to LOS susceptibility.

The elevated ratio of non-cytotoxic T to cytotoxic T/NK lymphocytes observed in our study is in keeping with the Th2-skewed response reported in early infancy [32, 33]. This skewing increases tolerance to pathogens, which is important for early life commensal colonisation, but may contribute to susceptibility to infection in infants [43]. Interestingly, we found that following LOS on days 21 and 28, preterm infants had reduced counts and frequencies of non-cytotoxic T lymphocytes compared to infants who did not develop LOS. Depleted circulating lymphocyte populations is a characteristic of sepsis-induced immunosuppression in adults, and is reported at post-mortem in preterm and term infants and children following fatal sepsis [4446]. Taken together, these data suggest a degree of immune suppression following LOS in our cohort of preterm infants.

Compared to infants without LOS, immature granulocytes remained elevated near the time of LOS, a finding consistent with previous neonatal sepsis studies [23].

Neutrophil-to-lymphocyte ratio

An elevated ratio of neutrophils to lymphocytes is a proposed biomarker for systemic inflammation in neonatal sepsis with an area under the curve of 0.78, sensitivity of 0.73 and specificity of 0.79 from receiver operating characteristic analysis [47]. We found that the ratio of neutrophils to lymphocytes was similar between preterm infants with and without LOS, indicating this ratio is a poor predictor of LOS in our cohort. The discrepancy in the ratio of neutrophils to lymphocytes in septic and non-septic infants between our study and those published, suggests that elevated ratios may not necessarily be present in the days or weeks leading up to and after LOS, likely due to the rapid inflammatory changes in response to infection [9]. Additionally, our leukocyte counts were adjusted known risk factors for LOS, which may refine the difference in neutrophil-to-lymphocyte ratio between infants with and without LOS.

Study strengths and limitations

The strengths of this study include the longitudinal prospective sample collection through the first month of life and detailed analysis of leukocyte populations from peripheral blood in real time, both of which are unusual in preterm infant studies. Our analyses were adjusted for known risk factors for LOS [2]. We acknowledge that there are some limitations of the study, including the generalised classification of leukocytes and lack of specific populations, particularly in the T cell compartment (e.g. CD4, CD8, regulatory T cells and other innate-like T cells), that are known to play specific roles in the immune response to bacterial infection [31, 33, 34, 48, 49]. The sample size is modest, reflecting the difficulties of repeated standardised sampling in this population, which limits relating our laboratory findings to clinical outcomes and the influence of maternal factors and antibiotic therapy that may influence leukocyte populations. Moreover, the investigation into potential differences between Gram-positive and Gram-negative infections was limited by the modest number of infants with LOS particularly due to organisms other than Coagulase-negative staphylococci. Sample collection at the time of sepsis evaluation was not permitted due to ethical reasons, limiting analyses to weekly time points. The lack of functional data precludes a mechanistic interpretation of the relationship of leukocyte counts and frequencies to LOS. The correlation between the 5-fluorophore-6-marker flow cytometry method and manual/automated counts for some cell populations (e.g. basophils, monocytes) in blood samples from newborn infants is low and interpreting the counts in this study as a reference range should be done with caution [15, 16].

Conclusions

This study adds to the limited knowledge of the composition of leukocyte populations in preterm infant, particularly for those who develop LOS. Decreased non-cytotoxic T lymphocytes following LOS may reflect immunosuppression. Future studies further characterising leukocyte populations, particularly immunosuppressive populations (e.g. regulatory T lymphocytes and myeloid-derived suppressor cells), using additional markers and advanced techniques, such as high dimensionality analysis, that allow for in-depth detection beyond conventional gating, will provide complementary information on early life immune development in infants.

Acknowledgments

The authors would like to thank all participating families. We would also like to thank Gail Abernethy, Annie Chang, Chooi Heen Kok, and the clinical staff at King Edward Memorial Hospital Neonatal Directorate for assistance with recruitment and sample collection. We acknowledge the generosity of the Pathwest Clinical Immunology Laboratory, including Roslyn Hackshaw, Tracie Easter and Monica Kemp for provision of flow cytometry expertise and equipment. Lastly, laboratory assistance from Karen Riley, Stephanie Trend and Melissa Whinnen is acknowledged.

References

  1. 1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162–72. pmid:22682464
  2. 2. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–91. pmid:12165580
  3. 3. Strunk T, Inder T, Wang X, Burgner D, Mallard C, Levy O. Infection-induced inflammation and cerebral injury in preterm infants. Lancet Infect Dis. 2014;14:751–62. pmid:24877996
  4. 4. Melvan JN, Bagby GJ, Welsh DA, Nelson S, Zhang P. Neonatal sepsis and neutrophil insufficiencies. Int Rev Immunol. 2010;29:315–48. pmid:20521927
  5. 5. Hornik CP, Benjamin DK, Becker KC, Benjamin DK Jr., Li J, Clark RH, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31:803–7. pmid:22531232
  6. 6. de Jong E, Strunk T, Burgner D, Lavoie PM, Currie A. The phenotype and function of preterm infant monocytes: implications for susceptibility to infection. J Leukoc Biol. 2017;102:645–56. pmid:28630102
  7. 7. Verbrugge SE, Huisman A. Verification and standardization of blood cell counters for routine clinical laboratory tests. Clin Lab Med. 2015;35:183–96. pmid:25676379
  8. 8. Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics. 1994;94:76–82. pmid:8008542
  9. 9. Strunk T, Hibbert J, Doherty D, Nathan E, Simmer K, Richmond P, et al. Impaired cytokine responses to live Staphylococcus epidermidis in preterm infants precede Gram-positive late-onset sepsis. Clin Infect Dis. 2021;72:271–8. pmid:31960030
  10. 10. Strunk T, van Haren SD, Hibbert J, Pettengill M, Ozonoff A, Jans J, et al. Cyclic AMP in human preterm infant blood is associated with increased TLR-mediated production of acute-phase and anti-inflammatory cytokines in vitro. Pediatr Res. 2020;88:717–25. pmid:31578034
  11. 11. Pettengill M, Matute JD, Tresenriter M, Hibbert J, Burgner D, Richmond P, et al. Correction: Human alkaline phosphatase dephosphorylates microbial products and is elevated in preterm neonates with a history of late-onset sepsis. PLoS One. 2017;13:e0197532.
  12. 12. Klingenberg C, Kornelisse RF, Buonocore G, Maier RF, Stocker M. Culture-Negative Early-Onset Neonatal Sepsis—At the Crossroad Between Efficient Sepsis Care and Antimicrobial Stewardship. Front Pediatr. 2018;6:285. pmid:30356671
  13. 13. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003;6:435–48. pmid:14708737
  14. 14. Faucher JL, Lacronique-Gazaille C, Frebet E, Trimoreau F, Donnard M, Bordessoule D, et al. "6 markers/5 colors" extended white blood cell differential by flow cytometry. Cytometry A. 2007;71:934–44. pmid:17879238
  15. 15. Gac F, Thibert JB, Le Berre C, Le Priol J, Semana G, Fest T, et al. Evaluation of CytoDiff™ on cord blood WBC differential. Int J Lab Hematol. 2013;35:46–54. pmid:22862853
  16. 16. van Vliet R, van den Tooren-de Groot HK, Van Rossum AP. Flow cytometric white blood differential using CytoDiff™ in the diagnosis of neonatal early-onset infection. J Matern Fetal Neonatal Med. 2017;30:2626–32. pmid:27834108
  17. 17. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, Romagnani S. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol. 2000;30:2972–9. pmid:11069080
  18. 18. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001;19:275–90. pmid:11244038
  19. 19. Björkström NK, Gonzalez VD, Malmberg KJ, Falconer K, Alaeus A, Nowak G, et al. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. J Immunol. 2008;181:4219–28. pmid:18768879
  20. 20. Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, et al. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood. 2013;121:3599–608. pmid:23487023
  21. 21. Fujimoto H, Sakata T, Hamaguchi Y, Shiga S, Tohyama K, Ichiyama S, et al. Flow cytometric method for enumeration and classification of reactive immature granulocyte populations. Cytometry. 2000;42:371–8. pmid:11135291
  22. 22. Oliver E, Sterba MS, Saini SS, Vonakis BM, Devine K. The expression of CRTh2 on blood basophils and eosinophils in chronic idiopathic urticaria. J Allergy Clin Immunol. 2015;AB126.
  23. 23. Cimenti C, Erwa W, Herkner KR, Kasper DC, Muller W, Resch B. The predictive value of immature granulocyte count and immature myeloid information in the diagnosis of neonatal sepsis. Clin Chem Lab Med. 2012;50:1429–32. pmid:22868809
  24. 24. Braakman E, van de Winkel JG, van Krimpen BA, Jansze M, Bolhuis RL. CD16 on human gamma delta T lymphocytes: expression, function, and specificity for mouse IgG isotypes. Cell Immunol. 1992;143:97–107. pmid:1377991
  25. 25. Mitchell RG. Circulating basophilic leucocyte counts in the newborn. Arch Dis Child. 1955;30:130–2. pmid:14377618
  26. 26. Schefold JC, Porz L, Uebe B, Poehlmann H, von Haehling S, Jung A, et al. Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis. J Perinat Med. 2015;43:609–18. pmid:25418981
  27. 27. Zasada M, Lenart M, Rutkowska-Zapala M, Stec M, Durlak W, Grudzien A, et al. Analysis of PD-1 expression in the monocyte subsets from non-septic and septic preterm neonates. PLoS One. 2017;12:e0186819. pmid:29049359
  28. 28. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277–92.e14. pmid:30142345
  29. 29. Schmutz N, Henry E, Jopling J, Christensen RD. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol. 2008;28:275–81. pmid:18200025
  30. 30. Juul SE, Haynes JW, McPherson RJ. Evaluation of eosinophilia in hospitalized preterm infants. J Perinatol. 2005;25:182–8. pmid:15578033
  31. 31. Walker JC, Smolders MA, Gemen EF, Antonius TA, Leuvenink J, de Vries E. Development of lymphocyte subpopulations in preterm infants. Scand J Immunol. 2011;73:53–8. pmid:21129003
  32. 32. Li S, Ma F, Hao H, Wang D, Gao Y, Zhou J, et al. Marked elevation of circulating CD19(+)CD38(hi)CD24(hi) transitional B cells give protection against neonatal sepsis. Pediatr Neonatol. 2018;59:296–304. pmid:29239829
  33. 33. Qazi KR, Bach Jensen G, van der Heiden M, Björkander S, Holmlund U, Haileselassie Y, et al. Extremely Preterm Infants Have Significant Alterations in Their Conventional T Cell Compartment during the First Weeks of Life. J Immunol. 2020;204:68–77. pmid:31801814
  34. 34. Kamdar S, Hutchinson R, Laing A, Stacey F, Ansbro K, Millar MR, et al. Perinatal inflammation influences but does not arrest rapid immune development in preterm babies. Nature communications. 2020;11:1284. pmid:32152273
  35. 35. Bektas S, Goetze B, Speer CP. Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm neonates. Acta Paediatr Scand. 1990;79:1031–8. pmid:2267919
  36. 36. Nupponen I, Turunen R, Nevalainen T, Peuravuori H, Pohjavuori M, Repo H, et al. Extracellular release of bactericidal/permeability-increasing protein in newborn infants. Pediatr Res. 2002;51:670–4. pmid:12032259
  37. 37. Deshmukh HS, Liu Y, Menkiti OR, Mei J, Dai N, O’Leary CE, et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med. 2014;20:524–30. pmid:24747744
  38. 38. Khosravi A, Yáñez A, Price JG, Chow A, Merad M, Goodridge HS, et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe. 2014;15:374–81. pmid:24629343
  39. 39. Teng RJ, Wu TJ, Garrison RD, Sharma R, Hudak ML. Early neutropenia is not associated with an increased rate of nosocomial infection in very low-birth-weight infants. J Perinatol. 2009;29:219–24. pmid:19078971
  40. 40. Manzoni P, Farina D, Monetti C, Priolo C, Leonessa M, Giovannozzi C, et al. Early-onset neutropenia is a risk factor for Candida colonization in very low-birth-weight neonates. Diagn Microbiol Infect Dis. 2007;57:77–83. pmid:17178299
  41. 41. Paul DA, Leef KH, Sciscione A, Tuttle DJ, Stefano JL. Preeclampsia does not increase the risk for culture proven sepsis in very low birth weight infants. Am J Perinatol. 1999;16:365–72. pmid:10614705
  42. 42. Piliponsky AM, Shubin NJ, Lahiri AK, Truong P, Clauson M, Niino K, et al. Basophil-derived tumor necrosis factor can enhance survival in a sepsis model in mice. Nat Immunol. 2019;20:129–40. pmid:30664762
  43. 43. Harbeson D, Ben-Othman R, Amenyogbe N, Kollmann TR. Outgrowing the Immaturity Myth: The Cost of Defending From Neonatal Infectious Disease. Front Immunol. 2018;9:1077. pmid:29896192
  44. 44. Hibbert JE, Currie A, Strunk T. Sepsis-Induced Immunosuppression in Neonates. Front Pediatr. 2018;6:357. pmid:30555806
  45. 45. Toti P, De Felice C, Occhini R, Schuerfeld K, Stumpo M, Epistolato MC, et al. Spleen depletion in neonatal sepsis and chorioamnionitis. Am J Clin Pathol. 2004;122:765–71. pmid:15491973
  46. 46. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol. 2005;174:3765–72. pmid:15749917
  47. 47. Alkan Ozdemir S, Arun Ozer E, Ilhan O, Sutcuoglu S. Can neutrophil to lymphocyte ratio predict late-onset sepsis in preterm infants? J Clin Lab Anal. 2018;32:e22338. pmid:29055117
  48. 48. Gibbons DL, Haque SF, Silberzahn T, Hamilton K, Langford C, Ellis P, et al. Neonates harbour highly active gammadelta T cells with selective impairments in preterm infants. Eur J Immunol. 2009;39:1794–806. pmid:19544311
  49. 49. Ravens S, Fichtner AS, Willers M, Torkornoo D, Pirr S, Schöning J, et al. Microbial exposure drives polyclonal expansion of innate γδ T cells immediately after birth. Proc Natl Acad Sci U S A. 2020;117:18649–60. pmid:32690687